Mexico''s Legalization of Medical Marijuana Yields Opportunities -- CFN Media
(firmenpresse) - SEATTLE, WA -- (Marketwired) -- 05/25/17 -- CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing Mexico''s pending legalization of medical marijuana, and (OTC PINK: MJNA) established position as a leader in the country''s nascent industry.
Mexico''s Lower House of Congress recently passed a bill that legalizes the use of medical marijuana and scientific research. In particular, the bill classifies the controversial psychoactive component of marijuana -- tetrahydrocannabinol or THC -- as "therapeutic". The move is akin to the U.S. Drug Enforcement Administration (DEA) rescheduling marijuana to a controlled substance that has therapeutic value for patients.
"The ruling eliminates the prohibition and criminalization of acts related to the medicinal use of marijuana and its scientific research, and those relating to the production and distribution of the plant for these purposes," read a Congressional statement.
The bill will now be sent to President Enrique Pena Nieto who is expected to sign it into law. While Pena Nieto was once a vocal opponent to legalization, his viewpoint has shifted to view drug use as a "public health problem" where users should not be criminalized. He even proposed a bill last year that would have permitted Mexicans to carry up to an ounce of marijuana, but that measure has since stalled in Congress.
Medical Marijuana Inc. has remained the only legal provider of CBD oils in Mexico through its HempMeds Mexico subsidiary. The company''s Real Scientific Hemp Oil -- or RSHO -- brand has become synonymous with ultra-high quality and reliability, which is why the government granted the company an exclusive import license for certain medical conditions including epilepsy and neuropathic pain. At the same time, RSHO-X (RSHO with absolutely no THC) has already been used in clinical studies evaluating the effects of CBD on epilepsy.
In March, HempMeds Mexico held a press conference in Mexico City revealing the positive results of a clinical study conducted by renowned physician Dr. Saul Garza Morales on the effects of RSHO-X in treating children with severe epilepsy. The 39-patient study of children with Lennox-Gastaut syndrome showed an 84% reduction in motor seizures, 53% improvement in quality of life, and seven individuals that reported a complete elimination of seizures which was television network.
The combination of a product already on the market and clinical data supporting its efficacy marks a significant competitive advantage compared to other products on the market. Given this early lead, the company is well positioned to capitalize on the market as restrictions are lifted and wider access is granted for cannabidiol and other cannabinoids that may have additional uses across many different medical conditions.
Learn how to become a CFN Media featured company, brand or entrepreneur:
Download the CFN Media iOS mobile app to access the world of cannabis from your smart phone:
Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone:
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.''s portfolio and investment companies, visit .
To see Medical Marijuana, Inc.''s video statement, .
Shareholders are also encouraged to visit the for discounted products.
Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC, which owns CFN Media and CannabisFN.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: .
CFN Media
Frank Lane
206-369-7050
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 25.05.2017 - 07:00 Uhr
Sprache: Deutsch
News-ID 1505854
Anzahl Zeichen: 8847
contact information:
Contact person:
Town:
SEATTLE, WA
Phone:
Kategorie:
Investment Services & Trading
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 242 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Mexico''s Legalization of Medical Marijuana Yields Opportunities -- CFN Media
"
steht unter der journalistisch-redaktionellen Verantwortung von
CFN Media (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
